COVID-19住院患者的吞咽与嗓音结局:观察性队列研究
本研究为英国伦敦单中心观察性队列研究,纳入2020年4月起2个月内因嗓音和/或吞咽评估转介言语语言治疗(SLT)的164例COVID-19住院成人。患者基线吞咽与嗓音损害明显,经SLT评估及个体化补偿策略后各项指标均显著改善(P<.0001),但出院时部分患者仍遗留损害。
要点
- COVID-19住院患者吞咽与嗓音损害明显,SLT评估与个体化补偿策略可带来显著改善。
- 出院时29.3%的吞咽障碍患者和56.1%的嗓音障碍患者仍存在损害,需延续管理。
- 气管切开患者70.9%成功拔管,拔管中位时间19天(IQR 16-27)。
核心结论
- COVID-19住院患者存在显著的嗓音与吞咽损害,应给予及时的SLT干预;患者通常经评估和个体化补偿策略治疗后改善。
研究设计与样本
- 观察性队列研究,纳入英国伦敦一家inner-city国家卫生服务体系医院2020年4月起2个月内因嗓音和/或吞咽评估转介SLT的164例COVID-19住院成人(男104例),年龄56.8±16.7岁。
主要发现
- 52.4%有气管切开,78.7%曾插管(平均15±6.6天),13.4%有新发神经功能损害,69.5%存在谵妄。
- 全部患者尝试个体化补偿策略,11%接受直接训练;基线的吞咽与嗓音损害明显,研究期间各项均显著改善(P<.0001)。
- 首次SLT评估后平均2天开始部分经口进食(IQR 0-8),出院时恢复 normal 进食饮水;但出院时29.3%(n=29)的吞咽障碍患者和56.1%(n=37)的嗓音障碍患者仍存在损害。
- 70.9%的气管切开患者成功拔管,拔管中位时间19天(IQR 16-27)。
- 37.3%在住院期间完成SLT干预,23.5%转至其他医院,17.1%需嗓音随访,7.8%需吞咽障碍社区随访。
关键数值与推荐
- 吞咽与嗓音疗效指标在SLT干预前后记录,嗓音采用Grade Roughness Breathiness Asthenia Strain Scale评估。
- 吞咽障碍出院时残留比例29.3%(n=29),嗓音障碍出院时残留比例56.1%(n=37)。
- 气管切开拔管率70.9%,拔管中位时间19天(IQR 16-27)。
临床怎么用
- 对COVID-19住院患者应建立及时的SLT转介与评估路径,重点覆盖吞咽与嗓音。
- 资源准备应针对气管切开拔管与吞咽、嗓音障碍的及时管理,并建立稳固的转诊与随访路径。
局限性
- 单中心观察性队列设计,样本来自转介SLT的住院患者,结果可能受选择偏倚影响;原文未报告对照组及长期随访数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the presentations and outcomes of inpatients with coronavirus disease 2019 (COVID-19) presenting with dysphonia and dysphagia to investigate trends and inform potential pathways for ongoing care. DESIGN: Observational cohort study. SETTING: An inner-city National Health Service Hospital Trust in London, United Kingdom. PARTICIPANTS: All adult inpatients hospitalized with COVID-19 (N=164) who were referred to Speech and Language Therapy (SLT) for voice and/or swallowing assessment for 2 months starting in April 2020. INTERVENTIONS: SLT assessment, advice, and therapy for dysphonia and dysphagia. MAIN OUTCOME MEASURES: Evidence of delirium, neurologic presentation, intubation, tracheostomy, and proning history were collected, along with type of SLT provided and discharge outcomes. Therapy outcome measures were recorded for swallowing and tracheostomy pre- and post-SLT intervention and Grade Roughness Breathiness Asthenia Strain Scale for voice. RESULTS: Patients (N=164; 104 men) aged 56.8±16.7 years were included. Half (52.4%) had a tracheostomy, 78.7% had been intubated (mean, 15±6.6d), 13.4% had new neurologic impairment, and 69.5% were delirious. Individualized compensatory strategies were trialed in all and direct exercises with 11%. Baseline assessments showed marked impairments in dysphagia and voice, but there was significant improvement in all during the study (P<.0001). On average, patients started some oral intake 2 days after initial SLT assessment (interquartile range [IQR], 0-8) and were eating and drinking normally on discharge, but 29.3% (n=29) of those with dysphagia and 56.1% (n=37) of those with dysphonia remained impaired at hospital discharge. A total of 70.9% tracheostomized patients were decannulated, and the median time to decannulation was 19 days (IQR, 16-27). Among the 164 patients, 37.3% completed SLT input while inpatients, 23.5% were transferred to another hospital, 17.1% had voice, and 7.8% required community follow-up for dysphagia. CONCLUSIONS: Inpatients with COVID-19 present with significant impairments of voice and swallowing, justifying responsive SLT. Prolonged intubations and tracheostomies were the norm, and a minority had new neurologic presentations. Patients typically improved with assessment that enabled treatment with individualized compensatory strategies. Services preparing for COVID-19 should target resources for tracheostomy weaning and to enable responsive management of dysphagia and dysphonia with robust referral pathways.
引用
- Archer SK, Iezzi CM, Gilpin L, et al. Swallowing and Voice Outcomes in Patients Hospitalized With COVID-19: An Observational Cohort Study. Arch Phys Med Rehabil. 2021. PMID: 33529610. doi:10.1016/j.apmr.2021.01.063
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。